Skip to main content
. 2016 Apr 26;20(3):253–259. doi: 10.4196/kjpp.2016.20.3.253

Fig. 2. Effect of KTH-13-t-Bu on proliferation of (A) C6 glioma, (B) MDA-MB-231, (C) LoVo, and (D) HCT-15 cells after treatment for 24 or 6 h.

Fig. 2

Cell viability was determined by the MTT assay. *p<0.05 and **p<0.01 compared with the normal group.